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Summary
Introduction:  Bilateral  total  knee  arthroplasty  (TKA)  in  a  one-stage  surgical  procedure  has  the
advantage  of  a  single  hospital  stay,  shorter  rehabilitation,  and  reduced  patient  management
costs. However,  until  now  the  use  of  this  strategy  has  been  limited  by  the  fear  of  a  higher  rate
of perioperative  complications.  The  hypothesis  of  this  study  was  that  in  selected  patients,  this
management  strategy  would  not  result  in  any  serious  complications.
Materials  and  methods:  This  prospective  24-month  pilot  study  was  performed  in  a  continu-
ous series  of  patients  without  a  control  group.  Inclusion  criteria  were  bilateral  non-infectious
gonarthropathy,  in  patients  classiﬁed  as  American  Society  of  Anesthesiology  (ASA)  1  or  2  and
presenting  with  a  preoperative  hemoglobin  level  of  at  least  13  g/dL.  All  patients  underwent  a
pre- and  postoperative  evaluation  using  the  International  Knee  Society  (IKS)  and  Knee  Injury
and Osteoarthritis  Score  (KOOS)  scores.
Results:  Thirty  patients  were  included  in  the  study  (25  women,  mean  age  70.3  years  old  [32
to 88  years];  ﬁve  ASA  1  and  25  ASA  2).  All  patients  were  followed-up  and  evaluated  for  a  mean
18 months  (6  to  30  months).  Three  deep  vein  thromboses,  one  cardiopulmonary  accident  and
three confusional  states  were  reported,  but  there  were  no  perioperative  deaths,  pulmonary
embolisms,  nosocomial  infections  or  revision  procedures.  At  18  months  follow-up  the  IKS  score
had improved  from  98  (33—139)  preoperatively  to  169  (62—200)  postoperatively.  The  ﬁve  items
of the  KOOS  score  improved  signiﬁcantly.
Discussion:  This  preliminary  series  conﬁrms  that  bilateral  total  knee  replacement  in  a  one-stage
surgical procedure  is  a  reliable  alternative  to  a  two-stage  procedure  in  ASA  1  and  2  patients.
Because of  the  savings  in  health  costs  with  this  strategy,  public  healthcare  authorities  should
 andprovide support  by  creating
Level of  evidence:  4,  prospectiv
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wo  thirds  of  the  patients  who  undergo  total  knee  arthro-
lasty  (TKA)  have  bilateral  degenerative  disease  [1]  and
0%  of  them  will  undergo  surgery  of  the  2nd  knee  within
 years  after  the  ﬁrst  [2].  Moreover,  when  the  disease  is
ilateral,  optimal  beneﬁt  is  only  possible  when  both  joints
re  replaced  [3].
The  two  possible  surgical  strategies  in  these  patients  who
equire  tri-compartmental  knee  replacement  are  bilateral
KA  performed  in  a  one-stage  surgical  procedure  with  one
ession  of  anesthesia,  or  bilateral  TKA  performed  in  two
eparate  surgical  procedures,  either  during  the  same  hos-
ital  stay  or  two  hospital  stays  between  1  and  12  months
part.  One-stage  bilateral  knee  replacement  has  been  eval-
ated  in  retrospective  [4—20]  and  prospective  [21]  studies
nd  throughout  the  world  the  use  of  one-stage  surgical  pro-
edures  has  increased  in  the  past  15  years.  At  present  they
epresent  for  example,  11%  of  the  knee  replacements  in  New
ealand  [15]  and  4%  in  the  United  States  [22].
Although  there  is  no  consensus,  most  authors  indicate
hese  one-stage  procedures  for  American  Society  of  Anes-
hesiology  (ASA)  1  or  2  patients  with  few  or  no  associated
omorbidities  [19,20].  Age  is  not  a  strict  exclusion  crite-
ion  [23]. Authors  emphasize  that  the  main  advantages  of
ne-stage  bilateral  surgery  are  the  reduced  cost  and  shorter
ospital  stay  compared  to  two-stage  surgery  [24—26]. More-
ver,  functional  recovery  has  been  found  to  be  satisfactory
fter  one-stage  bilateral  TKA  [27].
The  main  aim  of  this  prospective  study  of  a  continuous
eries  of  one-stage  bilateral  TKAs  was  to  evaluate  periopera-
ive  complications.  The  hypothesis  of  this  study  was  that,  in
elected  patients,  this  strategy  does  not  result  in  any  severe
omplications.
aterials and methods
his  was  a  24-month  prospective  pilot  study  in  a  continuous
eries  of  patients  without  a  control  group  (January  1,  2009
o  December  31,  2010).  Inclusion  criteria  were  primary  or
econdary  arthritis  or  non-infectious  bilateral  inﬂammatory
rthritis,  in  patients  classiﬁed  as  ASA  1  or  2  and  presenting
ith  a  preoperative  hemoglobin  level  of  at  least  13  g/dL.
on-inclusion  criteria  were  patients  who  refused  one-stage
ilateral  TKA.  Exclusion  criteria  were  ASA  3  or  4  patients  or
atients  presenting  with  deep  vein  thrombosis,  pulmonary
mbolism,  severe  obliterative  arthritis  of  the  lower  limbs
nd/or  revision  arthroplasties.
nesthesia  methodology
 systematic  anesthesia  consultation  took  place  one  month
efore  surgery  with  a  standardized  work-up  including  full
lood  count,  electrolyte  test,  coagulation  test,  chest  X-ray,
 recent  dental  examination  (less  than  6  months  old),  a  Cyto-
acteriological  examination  of  urine  (CBEU)  and  a  cardiac
xamination  (electrocardiogram  ±  echocardiography).  The
nesthesiologist  then  determined  whether  the  patient  was
pt  for  surgery  (ASA  score,  pre-existing  comorbidities)  and
rescribed  treatment  with  erythropoietin  [EPO]  if  necessary,
l
l
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o obtain  hemoglobin  level  greater  or  equal  to  13  g/dL  on  the
ay  of  surgery,  which  was  the  threshold  for  inclusion  in  our
tudy.  All  patients  signed  an  informed  consent  form  then
 joint  decision  was  made  by  the  orthopedic  surgeon  and
he  anesthesiologist  to  decide  whether  the  patient  would
e  managed  with  bilateral  one-stage  TKA.
Two  types  of  anesthesia  were  used:  epidural  nerve  block
ith  placement  of  an  epidural  catheter  for  72  hours  (as  well
s  systematic  placement  of  a  urinary  catheter)  or  general
nesthesia  with  a  perineural  femoral  catheter  and  a  ‘‘single
hot’’  sciatic  nerve  block.
urgical  procedure
rophylactic  intravenous  antibiotics:  2  g  of  cefazolin  (1st
eneration  cephalosporin)  were  administered  to  all  patients
uring  induction  of  anesthesia  then  1  g  every  8  hours  for
4  hours.
Either  an  anteromedial  approach  (varus  knee)  or  an
nterolateral  approach  (valgus  knee)  was  used.  A  cemented
olyethylene  ﬁxed  posterior  stabilized  implant  (Nexgen©
PS  —  Zimmer)  with  patellar  resurfacing  was  systematically
sed.
A  bilateral  sequential  pneumatic  tourniquet  was  used  in
ll  cases.  The  surgical  procedure,  performed  by  the  princi-
le  surgeon  and  investigator  in  the  study,  began  when  the
ourniquet  was  inﬂated.  Once  the  implant  was  cemented,
he  2nd  tourniquet  was  inﬂated  (double  tourniquet  period).
hile  the  surgeon  incised  the  2nd  knee,  assistants  closed  the
st  knee  and  the  tourniquet  was  released.  All  operated  knees
nderwent  postoperative  draining  with  two  Redon  drains  in
he  knee,  connected  to  the  perioperative  recovery  system
rthopath®. The  recovered  blood  was  ﬁltered  and  washed
n  the  recovery  room  then  retransfused  into  the  patient
ithin  6  hours.  Two  splints  were  placed  on  the  legs  in  the
perating  room.  Preventive  anticoagulant  therapy  with  low
eight  heparin  was  begun  within  12  hours  after  surgery  and
ontinued  for  15  days.
ehabilitation  program
mmediate  passive  mobilization  was  begun  on  a  Kinetec®
evice.  The  goal  was  to  achieve  complete  extension  and  90◦
exion  by  the  7th  day.  Patients  with  an  epidural  catheter  got
p  for  the  ﬁrst  time  3  days  after  surgery.  Those  with  general
nesthesia  and  a  femoral  catheter  got  up  on  the  2nd  day.  The
plint  was  worn  for  15  days.  All  patients  were  then  managed
n  a  rehabilitation  center.
re-,  peri-  and  postoperative  evaluation
ssessment  of  clinical  function  was  based  on  the  Inter-
ational  Knee  Society  (IKS)  score,  the  index  of  patient
atisfaction  [28]. Assessment  of  quality  of  life  was  based  on
he  subjective  Knee  Injury  and  Osteoarthritis  Score  (KOOS
29]).  Radiological  assessment  was  based  on  bilateral  AP  and
ateral  X-rays  of  the  knee,  a  30◦ and  60◦ tangential  view  and
ong  leg  weight  bearing  X-Rays.
An objective  clinical  assessment  was  performed  preop-
ratively  and  at  1  month,  3  months,  6  months  and  12  months
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Table  1  Perioperative  complications  according  to  age  and  American  Society  of  Anesthesiology  (ASA)  score.
Age <  70  years  old  70—80  years  old  >  80  years  old
Gender
Woman 9  9  7
Man 4 1 0
ASA Score
ASA  1 1 2 2
ASA  2  12  8  5
Complications
PE 0  0  0
DVT 1  (ASA  2)  1  (ASA  1)  1  (ASA  2)
Cardiac 0  1  (ASA  2)  0
Confusion 1  (ASA  2)  1  (ASA  2)  1  (ASA  2)
PE: pulmonary embolism; DVT: deep vein thrombosis.
Table  2  Objective  and  subjective  functional  results  at  18  months  of  follow-up  (6—30).
Preoperative  Postoperative  P  value
IKS  score
Knee  score  39  91  <  0.0001
Functional score  52  77  0.0034
KOOS score
Symptom  score  56  88  <  0.0001
Pain score  37  93  <  0.0001
Function score  36  87  <  0.0001
Activity, sports  and  leisure  activities  score  5  38  <  0.0001
Quality of  life  score  2  91  <  0.0001
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postoperatively.  Evaluation  criteria  were  the  mean  dura-
tion  of  surgery,  pre-  and  postoperative  hemoglobin
levels,  homologous  (allogeneic)  transfusions  and  immedi-
ate  postoperative  autologous  retransfusion,  total  estimated
postoperative  blood  loss  and  any  use  of  recombinant  eryth-
ropoietin  (rHU-EPO).  Mortality,  pulmonary  embolism  and
nosocomial  infection,  and  surgical  revision  rates  as  well  as
any  other  complications  were  recorded.  Duration  of  the  hos-
pital  stay  and  in  the  rehabilitation  center  was  recorded  for
each  patient.
Results
Thirty  patients  were  included  (11  patients  refused  one-
stage  knee  replacement  and  16  patients  accepted  but  were
excluded  after  the  anesthesia  consultation  because  they
were  ASA  3  in  12  cases  and  ASA  4  in  four  cases).  During  the
same  period  366  unilateral  total  knee  arthroplasties  were
performed  in  our  unit,  nine  unicompartmental  arthroplas-
ties,  nine  revision  unicompartmental  arthroplasties,  four
revision  TKAs  for  mechanical  failure  and  21  for  infections.
There  were  25  women  and  ﬁve  men,  mean  age  70.3  years
old  (32—88);  ﬁve  were  classiﬁed  as  ASA  1  and  25  ASA  2.  The
preoperative  diagnosis  was  primary  arthritis  in  23  patients,
secondary  arthritis  in  ﬁve  and  rheumatoid  arthritis  in  two.
Twenty-ﬁve  patients  received  epidural  nerve  block  with
a
o
o
pritis Outcome Score.
 catheter  and  ﬁve  patients  received  general  anesthesia
ith  femoral  catheters  and  sciatic  nerve  block.  Preopera-
ive  injections  of  rHU-EPO  were  prescribed  in  11  patients
o  reach  the  threshold  of  13  g/dL  of  hemoglobin  necessary
or  surgery  (a  subcutaneous  injection  of  600  UI/kg  rHU-EPO
er  week;  the  ﬁrst  injection  was  performed  3  weeks  before
he  planned  date  of  surgery).  An  iron  supplement  (200  to
00  mg  per  os  if  there  was  no  deﬁciency)  was  systematically
ssociated  with  EPO  to  promote  erythropoiesis.
The  mean  duration  of  surgery  was  98  minutes  (70  to
45  minutes).  All  patients  received  immediate  postopera-
ive  retransfusion  (330  ±  157  mL),  six  patients  received  a
omologous  transfusion  and  15  patients  received  postoper-
tive  EPO.  The  mean  hemoglobin  level  went  from  14.4  g/dL
13—16)  preoperatively  to  9.7  g/dL  (6.6—11.8)  postopera-
ively.  Total  estimated  postoperative  blood  loss  was  2713  mL
±  967  mL).
The  mean  hospital  stay  in  the  orthopedic  surgery  unit  was
0  days  (7  to  16  days)  and  the  mean  stay  in  the  rehabilitation
enter  was  40  days  (21  to  120  days).
Three  patients  presented  with  deep  vein  thrombosis  (at
ne,  four  and  eight  postoperative  weeks)  and  one  with  a  car-
iopulmonary  complication  (hypoventilation  syndrome  with 24-h  stay  in  intensive  care).  Three  confusional  states
ccurred  in  the  ﬁrst  postoperative  week,  and  a  bedsore
n  the  heel.  No  other  early  or  late  complications  (death,
ulmonary  embolism,  infection  or  myocardial  infarction)
860  C.  Trojani  et  al.
Table  3  Complications  in  one-stage  bilateral  bilateral  total  knee  arthroplasty  (TKA)  series.
Type  of  study  Authors  Year  No.  of
patients
Pulmonary
embolisms  (%)
TVP  (%)  Cardiac
complications  (%)
Infections  (%)
Retrospective Lynch  et  al.  [4]  1997  98  —  —  24.5  —
Cohen et  al.  [5]  1997  86  —  —  3.5  —
Lane et  al.  [6] 1997  100  —  —  18  —
Adili et  al.  [7] 2001 82 — —  15.8  —
Mantilla et  al.  [8] 2002 1410 — — 0.9  —
Bullock [9] 2003 255 0 1.6 2 0.4
Leonard  et  al.  [10]  2003  92  0  3.3  3.3  3.2
Ritter et  Harty  [11]  2004  2050  0.9  0.9  1.5  0.8
Pavone et  al.  [12]  2004  501  0.4  13  5.6  0.4
Hutchinson et  al.  [13]  2006  438  2.3
Barrett et  al.  [14]  2006  8324  1.4  —  —  —
Hooper et  al.  [15]  2009  1012  0.1  0.1  —  1.6
Kim et  al.  [16]  2009  2385  0.8  0.3  0.5  1.9
Luscombe et  al.  [17]  2009  72  1.4  1.4  5.6  3.5
Shin et  al.  [18]  2010  308  0.3  1.3  3.6  3.2
Yoon et  al.  [19]  2010  119  0  0  0  2.5
Memtsoudis et  al.  [20]  2011  206,573  1.5  1.5  6.53  0.2
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iProspective Peak  et  al.  [21]  2008  100  
ccurred  (Table  1).  None  of  the  patients  had  undergone  revi-
ion  surgery  at  follow-up,  but  two  of  them  presented  with
 patellar  subluxation  and  two  others  with  frontal  laxity
ithout  instability.
The  objective  and  subjective  results  are  summarized  in
able  2.  All  patients  were  satisﬁed  or  very  satisﬁed  with  the
urgical  procedure.  None  of  them  regretted  being  treated
ith  the  one-stage  procedure.
iscussion
his  study  conﬁrms  that  there  are  no  serious  complications
n  selected  patients  who  undergo  bilateral  total  knee
rthroplasty  with  a  one-stage  procedure  [16,19].  No  cases
f  early  revision  surgery,  pulmonary  embolism,  cardiac
omplications,  acute  infection,  severe  bleeding  or  death
ere  observed.  Three  cases  of  deep  vein  thrombosis  and
hree  transient  confusional  states  were  recorded.  At  the
nal  follow-up  none  of  the  patients  had  undergone  revision
urgery.  Based  on  these  preliminary  results,  the  authors  are
ontinuing  this  strategy  with  the  same  inclusion  criteria,
ither  in  ASA  1  or  2  patients  presenting  with  preoperative
emoglobin  levels  of  at  least  13  g/dL.
However,  the  results  in  the  literature  are  controversial.
he  complications  described  in  the  series  in  the  literature
re  summarized  in  Table  3.  For  certain  authors  the  risk  of
omplications  is  increased  with  bilateral  TKA.  In  particu-
ar  the  rate  of  deep  vein  thrombosis,  pulmonary  embolism,
ardiac  complications  and  death  is  higher  [20,22,26]. In
007,  Restrepo  [30]  compared  16,419  bilateral  TKA  to
0,930  unilateral  TKA  and  found  that  morbidity-mortality
as  higher  in  the  bilateral  group.  In  2011,  Memtsoudis  [20]
nalyzed  206,573  bilateral  TKA  performed  between  1998  and
007  in  the  United  States  and  concluded  that  extremely
lderly  patients  and  ASA  3  or  4  patients,  have  a  major  risk
c
d
e
t 2  6  2
f  severe  complications.  Therefore  bilateral  TKA  should  be
ontraindicated  in  these  patients.  Restrepo  and  Memtsoudis
re  the  two  authors  who  have  analyzed  the  greatest  number
f  cases  of  bilateral  TKA.  However,  their  statistics  com-
are  bilateral  and  unilateral  TKA.  Neither  of  these  authors
ompared  one-stage  bilateral  TKA  to  two-stage  procedures.
ther  authors  have  performed  this  comparison  [11,15,16].
n  2004,  Ritter  [11]  evaluated  more  than  2000  patients,  in
009,  Hooper  [15]  more  than  1000  patients  and  in  2009,  Kim
16]  more  than  2300  patients  who  underwent  bilateral  TKA.
hese  were  single  center  studies  and  all  three  concluded
hat  there  was  no  additional  risk  in  the  one-stage  bilateral
KA  groups  than  in  the  two-stage  bilateral  TKA  groups.
Our  study  only  included  ASA  1  and  2  patients.  According
o  Memtsoudis,  ASA  3  and  4  patients  have  a  higher  risk  of
evere  complications  [20]. In  a  single  center  study  Yoon  [19]
eached  the  same  conclusion  and  found  that  the  compli-
ation  rate  in  ASA  3  and  4  patients  was  20%  compared  to
%  in  ASA  1  and  2  patients.  It  therefore  seems  logical  not
o  include  ASA  3  and  4  patients  in  the  bilateral  TKA  group.
hus,  the  decision  to  operate  is  made  after  the  anesthesia
onsultation  and  once  the  ASA  score  has  been  determined.
The  two  main  disadvantages  of  a  one-stage  surgical  pro-
edure  are  longer  surgery  and  increased  bleeding.  Although
he  procedure  is  indeed  longer  (98  minutes  in  our  study)  it
s  always  less  than  the  sum  of  two  arthroplasty  sessions.
Most  available  studies  insist  upon  the  amount  of  bleed-
ng  in  one-stage  bilateral  procedures.  Certain  studies  have
ompared  the  mean  amount  of  bleeding  between  simul-
aneous  and  staged  TKA,  with  respectively  1299  mL  versus
302  mL  [19]  and  1701  mL  versus  896  mL  [31]. Nevertheless
t  is  difﬁcult  to  compare  these  studies  because  the  method  of
alculating  blood  loss  was  not  standardized  and  the  standard
eviations  were  signiﬁcant.  Thus  the  sum  of  blood  loss  for
ach  intervention  in  two-stage  bilateral  TKA  may  be  greater
han  that  in  one-stage  TKA  [19]. However,  whatever  the
edu
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study,  the  level  of  blood  loss  is  high,  between  1300  and
2700  mL.  Thus  blood  loss  must  be  anticipated,  because  the
need  for  transfusion  in  one-stage  bilateral  TKA  is  high.
The  blood  saving  strategy  was  the  following:  the  level
of  hemoglobin  in  the  blood  was  increased  preoperatively  to
reach  the  threshold  of  13  g/dL  [32]  thanks  to  injections  of
recombinant  erythropoietin  [33,34]  associated  with  oral  iron
supplements.  An  injection  of  EPO  increases  the  hemoglobin
level  by  approximately  1  g/dL.  Preoperative  tranexamic  acid
can  reduce  the  need  for  homologous  transfusion  without
increasing  thrombotic  side  effects  [35,36].  Moreover  by
connecting  the  cell  saver  [37]  to  the  Redon  drains,  blood
collection  and  an  autologous  retransfusion  can  be  performed
within  6  hours.  Finally,  patients  can  receive  an  injection  of
erythropoietin  associated  with  oral  iron  supplements.
This  study  was  limited  by  the  small  size  of  the  patient
group,  the  lack  of  control  group,  and  the  lack  of  cost-
analysis.  Other  studies  including  much  larger  groups,  a
multicenter  study  with  the  same  inclusion  criteria,  or  a
case  control  study  would  help  conﬁrm  our  conclusions.  The
absence  of  a  control  group  limits  the  level  of  evidence  of
our  study,  but  it  should  be  noted  that  although  there  are
comparative  studies  in  the  literature,  there  are  no  pro-
spective  randomized  studies  of  bilateral  TKA  comparing  1
stage  and  2  stage  surgical  procedures  [38]. Because  there
is  no  cost-analysis  study,  the  healthcare  savings  could  not
be  determined  for  this  strategy  in  France,  although  this  has
been  evaluated  in  other  studies  [25,26,39].
Conclusion
This  study  shows  that  in  selected  patients  (ASA  1  and  2)
bilateral  TKA  in  a  one-stage  procedure  does  not  result  in
severe  complications.  The  main  disadvantage  of  this  strat-
egy  is  the  increase  in  blood  loss  that  must  be  planned  and
compensated  for.  Based  on  these  results,  the  public  health-
care  authorities  should  provide  support  by  creating  a  speciﬁc
group  of  patients  to  facilitate  further  studies.
Disclosure of interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.
References
[1] Legré V, Boyer T. Diagnostic et traitement d’un genou
douloureux. EMC-Appareil locomoteur 2003 [14-325-A-10].
[2] Ritter M, Mamlin LA, Melﬁ CA, Katz BP, Freund DA, Arthur
DS. Outcome implication for the timing of bilateral total knee
arthroplasties. Clin Orthop Relat Res 1997;345:99—105.
[3] Stanley D, Stockley I, Getty CJ. Simultaneous or staged
bilateral total knee replacements in rheumatoid arthritis: a
prospective study. J Bone Joint Surg Br 1990;72:772—4.
[4] Lynch NM, Trousdale RT, Ilstrup DM. Complications after con-
comitant bilateral knee arthroplasty in elderly patients. Mayo
Clin Proc 1997;72:799—805.
[5] Cohen RG, Forrest CJ, Benjamin JB. Safety and efﬁcacy of bilat-
eral total knee arthroplasty. J Arthroplasty 1997;12:497—502.
[6] Lane GJ, Hozack WJ, Shah S, et al. Simultaneous bilateral ver-
sus unilateral total knee arthroplasty. Outcomes analysis. Clin
Orthop Relat Res 1997;345:106—12.
[re  861
[7] Adili A, Bhandari M, Petruccelli D, De Beer J. Sequential
bilateral total knee arthroplasty under one anesthetic in
patients > or = 75 years old: complications and functional out-
comes. J Arthroplasty 2001;16:271—8.
[8] Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown
DL. Frequency of myocardial infarction, pulmonary embolism,
deep venous thrombosis, and death following primary hip or
knee arthroplasty. Anaesthesiology 2002;96:1140—6.
[9] Bullock DP, Sporer SM, Shirreffs Jr TG. Comparison of simul-
taneous bilateral with unilateral total knee arthroplasty in
terms of perioperative complications. J Bone Joint Surg Am
2003;85:1981—6.
10] Leonard L, Williamson DM, Ivory JP, Jennison C. An evaluation
of the safety and efﬁcacity of simultaneous bilateral total knee
arthroplasty. J Arthroplasty 2003;18:972—8.
11] Ritter MA, Harty LD. Debate: simultaneous bilateral knee
replacements: the outcomes justify its use. Clin Orthop Relat
Res 2004;428:84—6.
12] Pavone V, Johnson T, Saulog PS, Sculco TP, Bottner F. Periopera-
tive morbidity in bilateral one-stage total knee replacements.
Clin Orthop Relat Res 2004;421:155—61.
13] Hutchinson JR, Parish EN, Cross MJ. A comparison of bilateral
uncemented total knee arthroplasty: simultaneous or staged.
J Bone Joint Surg Br 2006;88:40—3.
14] Barrett J, Baron JA, Losina E, Wright J, Mahomed NN, Katz
JN. Bilateral total knee replacement: staging and pulmonary
embolism. J Bone Joint Surg Am 2006;88:2146—51.
15] Hooper GJ, Hooper NM, Rothwell AG, Hobbs T. Bilateral total
joint arthroplasty. The early results from the New Zealand
national joint registry. J Arthroplasty 2009;24:1174—7.
16] Kim YH, Choi YW, Kim JS. Simultaneous bilateral sequential
total knee replacement is as safe as unilateral total knee
replacement. J Bone Joint Surg Br 2009;91:64—8.
17] Luscombe JC, Theivendran K, Abudu A, Carter SR. The relative
safety of one-stage bilateral total knee arthroplasty. Int Orthop
2009;33:101—4.
18] Shin YH, Kim MH, Ko JS, Park JA. The safety of simultaneous
bilateral versus unilateral total knee arthroplasty: the experi-
ence in a Korean hospital. Singapore Med J 2010;51:44—9.
19] Yoon HS, Han CD, Yang IH. Comparison of simultaneous
bilateral and staged bilateral total knee arthroplasty in
terms of perioperative complications. J Arthroplasty 2010;25:
179—85.
20] Memtsoudis SG, Ma Y, Chiu YL, Poultsides L, Gonzalez Della
Valle A, Mazumdar M. Bilateral total knee arthroplasty: risk
factors for major morbidity and mortality. Anesth Analg
2011;113(4):784—90.
21] Peak EL, Hozack WJ, Sharkey PF, Rothman RH. One-stage
bilateral total joint arthroplasty: a prospective, comparative
study of total hip and total knee replacement. Orthopaedics
2008;31:131.
22] Memtsoudis SG, Della Valle AG, Besculides MC, Gaber L,
Sculco TP. In-hospital complications and mortality of uni-
lateral, bilateral, and revision TKA. Clin Orthop Relat Res
2008;466:2617—27.
23] Severson EP, Mariani EM, Bourne MH. Bilateral total knee
arthroplasty in patients 70 years and older. Orthopedics
2009;32:316.
24] Ritter MA, Harty LD, Davis KE, Meding JB, Berend M. Simultane-
ous bilateral, and unilateral total knee arthroplasty. A survival
analysis. J Bone Joint Surg Am 2003;85:1532—7.
25] Macario A, Schilling P, Rubio R, Goodman S. Economics of one-
stage versus two-stage bilateral total knee arthroplasties. Clin
Orthop Relat Res 2003;414:149—56.26] Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M,
Shim SD. Cost comparison between bilateral simultaneous,
staged, and unilateral total joint arthroplasty. J Arthroplasty
1998;13:172—9.
8[
[
[
[
[
[
[
[
[
[
[
[62  
27] Liu PL, Li L, Zhang YK, Li M, Kane K, Wang YH, et al. A compari-
son of two rehabilitation protocols after simultaneous bilateral
total knee arthroplasty: a controlled, randomized study. J Int
Med Res 2009;37:746—56.
28] Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the
knee society clinical rating system. Clin Orthop Relat Res
1989;248:13—4.
29] Roos EM, Roos HP, Lohmander LS, et al. Knee Injury and
Osteoarthritis Outcome Score (KOOS) — development of a self-
administered outcome measure. J Orthop Sports Phys Ther
1998;28:88—96.
30] Restrepo C, Parvizi J, Dietrich T, Einhorn TA. Safety of simul-
taneous bilateral total knee arthroplasty. A meta-analysis. J
Bone Surg Am 2007;89:1220—6.
31] Stubbs G, Pryke SE, Tewari S, Rogers J, Crowe B, Bridgfoot L,
et al. Safety and cost beneﬁts of bilateral total knee replace-
ment in an acute hospital. ANZ J Surg 2005;75:739—46.
32] Faris MP, Spence RK, Larholt KM, et al. The predictive power
of baseline hemoglobin for transfusion risk in surgery patients.
Orthopedics 1999;22:s135—40.
33] Goodnough LT, Skikne B, Brugnara C. Erythropoïetin, iron, and
erythropoiesis. Blood 2000;96:823—33.
[C.  Trojani  et  al.
34] Bezwada HP, Nazarian DG, Henry DH, Booth Jr RE. Preoperative
use of recombinant human erythropoietin before total joint
arthroplasty. J Bone Joint Surg Am 2003;85:1795—800.
35] Cid J, Lozano M. Tranexamic acid reduces allogenic red cell
transfusions in patients undergoing total knee arthroplasty:
results of a meta-analysis of randomized controlled trials.
Transfusion 2005;45:1302—7.
36] Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti
P, Auboyer C, et al. Do antiﬁbrinolytics reduce allo-
genic blood transfusion in orthopedic surgery. Anesthesiology
2006;105:1034—46.
37] Weinstein H, Keggi JM, Zatorski LE, Keggi KJ. One-stage
bilateral total hip arthroplasty in patients > or = 75 years.
Orthopaedics 2002;25:153—6.
38] Dimitris CN, Taylor BC, Mowbray JG, Steensen RN, Gaines ST.
Perioperative morbidity and mortality of 2-team simultane-
ous bilateral total knee arthroplasty. Orthopedics 2011;34:
e841—6.39] Della Valle CJ, Idjadi J, Hiebert RN, Jaffe W. The impact
of medicare reimbursement policies on simultaneous bilat-
eral total hip and knee arthroplasty. J Arthroplasty 2003;18:
29—34.
